Pentorex
Source: Wikipedia, the free encyclopedia.
Chemical compound
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
| |
NY (what is this?) (verify) |
Pentorex (Modatrop), also known as phenpentermine or α,β-dimethylamphetamine, is a stimulant drug related to phentermine which is used as an anorectic to assist with weight loss.[1][2] It also acts as a diuretic.[3] Pentorex was developed by Nordmark in the 1960s.[4]
References
- PMID 14090434.
- PMID 5897218.
- S2CID 46237660.
- ^ GB patent 995063, "A Substituted Butylamine and Salts thereof", issued 1965-06-10, assigned to Nordmark
antagonists
receptor agonists
- Beloranib§
- Bimagrumab§
- Desiccated thyroid‡
- Metformin
- Metreleptin
- Naltrexone
- Setmelanotide
- Topiramate
- ZGN-1061
- Zonisamide
- Water
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
Retrieved from "https://en.wikipedia.org/w/index.php?title=Pentorex&oldid=1207597180"